chlorpromazine has been researched along with (4-(m-chlorophenylcarbamoyloxy)-2-butynyl)trimethylammonium chloride in 1 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 1 (100.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Beleslin, DB; Nedelkovski, V | 1 |
1 other study(ies) available for chlorpromazine and (4-(m-chlorophenylcarbamoyloxy)-2-butynyl)trimethylammonium chloride
Article | Year |
---|---|
Emesis induced by 4-(m-chlorophenylcarbamoyloxy)-2-butynyltrimethylammonium chloride (McN-A-343): evidence for a predominant central muscarinic M1 mediation.
Topics: (4-(m-Chlorophenylcarbamoyloxy)-2-butynyl)trimethylammonium Chloride; 5,6-Dihydroxytryptamine; alpha-Methyltyrosine; Animals; Antazoline; Bretylium Compounds; Cats; Chlorpromazine; Choline; Emetics; Female; Hemicholinium 3; Hexamethonium Compounds; Injections, Intraventricular; Male; Mecamylamine; Methyltyrosines; Methysergide; Neuromuscular Blocking Agents; Propranolol; Quaternary Ammonium Compounds; Receptors, Muscarinic; Reserpine; Yohimbine | 1988 |